DMAC vs EVRG · $157.4M cap vs P/E 22, rev $5.85B
DiaMedica Therapeutics Inc (DMAC) versus Evergy, Inc. (EVRG) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Evergy, Inc. (EVRG) is a utilities - regulated electric company listed on NASDAQ.
DMAC does not have a complete income-statement cache yet.
Latest reported EVRG revenue for 2024-12-31 was $5.85B. Net income was $885.8M. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
DMAC currently screens at market cap $157.4M. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
Not investment advice. Open the DMAC and EVRG stock pages for the full models.
Not investment advice.